AlphAIAlphAI — Financial news for AI agents
investing.com$MRTN

Marten Transport earnings missed by $0.03, revenue fell short of estimates

Marten Transport (MRTN) reported Q3 EPS of $0.04, missing estimates by $0.03, with revenue at $223.12M, below the $230.03M consensus. The stock is down 24.54% over the last 3 months but up 15.06% year-over-year. InvestingPro rates its financial health as 'fair performance.'

Original reporting
investing.com
Published Oct 22, 2026, 9:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 22, 2026, 9:15 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$MRTN
Bearish
high confidence
Mentioned
$MRTN
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$MRTNBearishMed
01

Why it matters

The earnings miss may trigger a sell-off, but the stock's 12‑month uptrend suggests some resilience.

02

Market read

Earnings miss is the primary catalyst for short-term price movement in MRTN.

03

What to watch

Potential cost controls or upcoming contract wins not mentioned could mitigate the impact.

Relevance 7/10Novelty 8/10Timing: post-market today

Background

Marten Transport (NASDAQ:MRTN) is a regional trucking company; the article reports its Q3 earnings.

Company-level read

Ticker impact

$MRTNBearishHigh confidence
Context

Q3 earnings miss: EPS $0.04 vs $0.07 estimate and revenue $223.12M vs $230.03M consensus.

Expected impact

downward pressure as market prices in the miss

Evidence & confidence

Both EPS and revenue fell short of expectations, and the stock closed lower; traders may sell on the surprise.

Market effects

Sector

Transport and logistics sector may see modest pullback as a peer reports weaker results.

Regional

U.S. small-cap transport stocks could face short-term downside.

Global

Limited to niche transport investors; no broad market effect.

Counterpoint

What could challenge this read

If the miss is seen as a temporary setback and the company has solid balance sheet, long positions could be considered.

Key entities

  • company
    Marten Transport

    Regional trucking firm reporting Q3 results.

Read at source← All news

Related articles

$MRTNMed

MARTEN TRANSPORT ANNOUNCES THIRD QUARTER RESULTS

MARTEN TRANSPORT LTD (MRTN) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 MARTEN TRANSPORT ANNOUNCES THIRD QUARTER RESULTS MONDOVI, Wis., October 22, 2026 (GLOBE NEWSWIRE) -- Marten Transport, Ltd. (Nasdaq/GS:MRTN) today reported a 30.7% improvement in net income to $2.9 million, or 4 cents per diluted share, for the third quarter ended Se

SEC EDGAR 8-K
$MRTNMed

MARTEN TRANSPORT ANNOUNCES SECOND QUARTER RESULTS

MARTEN TRANSPORT LTD (MRTN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_990661.htm EXHIBIT 99.1 ex_990661.htm Exhibit 99.1 MARTEN TRANSPORT ANNOUNCES SECOND QUARTER RESULTS MONDOVI, Wis., July 23, 2026 (GLOBE NEWSWIRE) -- Marten Transport, Ltd. (Nasdaq/GS:MRTN) today reported net income of $5.3 million, or 7 cents per diluted share, for

SEC EDGAR 8-K
$SGPMedAI 8/10

SpyGlass Pharma Reports Third Quarter 2026 Financial Results and Provides Corporate Updates

SpyGlass Pharma, Inc. (SGP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 SpyGlass Pharma Reports Third Quarter 2026 Financial Results and Provides Corporate Updates • Acquired Advanced Vision Science, Inc. (AVS), securing scalable commercial intraocular lens (IOL) manufacturing capacity for its Phase 3 lead product candidate the Bimatopro

SEC EDGAR 8-K
$ONDSHighAI 8/10

Ondas Posts Record Q3 2026 Revenue of $167.5 Million on Strong Bookings and Backlog Growth; Raises Full-Year Outlook

Ondas Inc. (ONDS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Ondas Posts Record Q3 2026 Revenue of $167.5 Million on Strong Bookings and Backlog Growth; Raises Full-Year Outlook Record Q3 revenue of $167.5 million, up 100% sequentially and more than 16-fold year over year; pro forma organic revenue grew 64% year-over-year Capt

SEC EDGAR 8-K
$MOVEMed

Corvex Reports Third Quarter 2026 Results

Corvex, Inc. (MOVE) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Corvex Reports Third Quarter 2026 Results ARLINGTON, Va., Nov. 12, 2026 /PRNewswire/ -- Corvex, Inc. (Nasdaq: MOVE), an engineering-led AI computing platform specializing in GPU-accelerated infrastructure for AI workloads, today reported financial results for the thi

SEC EDGAR 8-K
$AVLNMed

Avalyn Pharma 3Q 2026: EPS ($0.67) — 10-Q Summary

Avalyn Pharma reported a wider net loss of $29.66M in Q3 2026, up 25.7% YoY, driven by higher R&D and administrative expenses. Diluted EPS was ($0.67). The company provided updates on clinical trials for AP01, AP02, and AP03, with topline data expected in late 2027. R&D costs increased by $3.4M, primarily due to AP02 trial expenses.

tradingview.com